Evidence map›Paper›PMID 38432713›Full record

ArticleThe American journal of clinical nutrition2024

Chronic and postprandial effect of blueberries on cognitive function, alertness, and mood in participants with metabolic syndrome - results from a six-month, double-blind, randomized controlled trial.

Peter J Curtis, Vera van der Velpen, Lindsey Berends, Amy Jennings, Laura Haag, Anne-Marie Minihane, Preeti Chandra, Colin D Kay, Eric B Rimm, Aedín Cassidy

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The American journal of clinical nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02035592 (The Effects of Blueberry Anthocyanins on Insulin Resistance and Vascular, Lung and Cognitive Function in a Population With Metabolic Syndrome.), which is not on this map. Cited by 8 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 4 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02035592 nacompletednot on this map

The Effects of Blueberry Anthocyanins on Insulin Resistance and Vascular, Lung and Cognitive Function in a Population With Metabolic Syndrome.

TypeinterventionalSponsorUniversity of East AngliaRan2014 to 2016Enrolled144ConditionsInsulin Resistance, Metabolic Syndrome XArmsFull dose blueberry, Half dose blueberry, Control
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 4 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Peter J CurtisNutrition and Preventive Medicine Group, Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, United Kingdom.
Vera van der VelpenNutrition and Preventive Medicine Group, Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, United Kingdom.
Lindsey BerendsNutrition and Preventive Medicine Group, Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, United Kingdom.
Amy JenningsInstitute for Global Food Security, Nutrition and Preventive Medicine, School of Biological Sciences, Queen's University Belfast, Northern Ireland.
Laura HaagNutrition and Preventive Medicine Group, Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, United Kingdom.
Anne-Marie MinihaneNutrition and Preventive Medicine Group, Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, United Kingdom.
Preeti ChandraFood Bioprocessing and Nutrition Sciences, Plants for Human Health Institute, North Carolina State University, North Carolina Research Campus, Kannapolis, NC, United States.
Colin D KayDepartment of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Eric B RimmDepartments of Epidemiology and Nutrition, Harvard T.H. Chan School of Public Health, and Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Aedín CassidyInstitute for Global Food Security, Nutrition and Preventive Medicine, School of Biological Sciences, Queen's University Belfast, Northern Ireland. Electronic address: a.cassidy@qub.ac.uk.
University of East Anglia · GBBrigham and Women's Hospital · USNorth Carolina State University · USQueen's University Belfast · GBUniversity of Arkansas for Medical Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnthocyanin and blueberry intakes positively associated with cognitive function in population-based studies and cognitive benefits in randomized controlled trials of adults with self-perceived or clinical cognitive dysfunction. To date, adults with metabolic syndrome (MetS) but without cognitive dysfunction are understudied.

objectivesCognitive function, mood, alertness, and sleep quality were assessed as secondary end points in MetS participants, postprandially (>24 h) and following 6-mo blueberry intake.

methodsA double-blind, randomized controlled trial was conducted, assessing the primary effect of consuming freeze-dried blueberry powder, compared against an isocaloric placebo, on cardiometabolic health >6 mo and a 24 h postprandial period (at baseline). In this secondary analysis of the main study, data from those completing mood, alertness, cognition, and sleep assessments are presented (i.e., n = 115 in the 6 mo study, n = 33 in the postprandial study), using the following: 1) Bond-Lader self-rated scores, 2) electronic cognitive battery (i.e., testing attention, working memory, episodic memory, speed of memory retrieval, executive function, and picture recognition), and 3) the Leeds Sleep Evaluation Questionnaire. Urinary and serum anthocyanin metabolites were quantified, and apolipoprotein E genotype status was determined.

resultsPostprandial self-rated calmness significantly improved after 1 cup of blueberries (P = 0.01; q = 0.04; with an 11.6% improvement compared with baseline between 0 and 24 h for the 1 cup group), but all other mood, sleep, and cognitive function parameters were unaffected after postprandial and 6-mo blueberries. Across the ½ and 1 cup groups, microbial metabolites of anthocyanins and chlorogenic acid (i.e., hydroxycinnamic acids, benzoic acids, phenylalanine derivatives, and hippuric acids) and catechin were associated with favorable chronic and postprandial memory, attention, executive function, and calmness.

conclusionsAlthough self-rated calmness improved postprandially, and significant cognition-metabolite associations were identified, our data did not support strong cognitive, mood, alertness, or sleep quality improvements in MetS participants after blueberry intervention. This trial was registered at clinicaltrials.gov as NCT02035592.

Indexed as

Blueberry PlantsMetabolic SyndromeAdultAnthocyaninsAttentionCognitionHumansPostprandial PeriodRandomized Controlled Trials as TopicAnthocyaninsanthocyanin-derived phenolic acid metabolitesblueberry anthocyaninscognitive functionmetabolic syndrome

Identifiers

PMID38432713
PMCPMC10972710
OpenAlexW4391558441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.